Galera Therapeutics, Inc. (GRTXD) SEC Filings

Ikarian Capital, LLC and Neil Shahrestani filed Amendment No. 1 to a Schedule 13G regarding Galera Therapeutics, Inc. common stock. The amendment reports that the Reporting Persons now have beneficial ownership of 0.00 shares and 0% of the class, with no sole or shared voting or dispositive power over any Galera Therapeutics shares.

The filing explains that a fund and certain separately managed accounts advised by Ikarian Capital are the record owners of the securities previously covered, and details how investment discretion is exercised. Each party, including the fund and the managed accounts, disclaims beneficial ownership of the other’s shares and also disclaims being part of a group for purposes of Section 13(d) or 13(g).